Xinafoate salt of a substituted 5-oxazol-2-yl-quinoline compound
US7919505B2 · kind B2 · utility
0Cited by
8References
44Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 10, 2007 |
| Grant date | Apr 5, 2011 |
| Priority date | — |
| Expiry date | Dec 1, 2029 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to the compound of the formulaTo methods of treating upper and lower obstructive airway diseases using said compound, to formulations comprising it, and to polymorphs and processes of synthesis of the polymorphic forms.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.